Roivant Sciences Ltd. 13D and 13G filings for Immunovant, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-15 4:30 pm Purchase | 2025-01-13 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 96,660,341 56.900% | 16,845,010 (+21.10%) | Filing |
| 2023-10-04 5:19 pm Purchase | 2023-10-02 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 79,815,331 55.300% | 6,416,667 (+8.74%) | Filing |
| 2021-08-02 08:23 am Purchase | 2021-08-02 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 73,398,664 63.800% | 17,021,276 (+30.19%) | Filing |
| 2021-03-08 08:00 am Unchanged | 2021-03-08 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.500% | 0 (Unchanged) | Filing |
| 2020-09-18 4:32 pm Purchase | 2020-09-17 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.600% | 8,773,969 (+18.43%) | Filing |
| 2020-09-04 5:29 pm Purchase | 2020-09-04 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 47,603,419 54.200% | 380,000 (+0.80%) | Filing |
| 2020-05-14 7:24 pm Purchase | 2020-05-12 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 47,223,419 62.100% | 8,773,969 (+22.82%) | Filing |
| 2020-04-17 5:27 pm Purchase | 2020-04-16 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 38,449,450 58.200% | 1,034,483 (+2.76%) | Filing |